Company attributes
Location
CEO
AngelList URL
Pitchbook URL
Legal Name
GeoVax Labs, Inc.
Legal classification
Date Incorporated
2008
Number of Employees (Ranges)
11 – 50
Email Address
info@geovax.com0
investor@geovax.com0
hr@geovax.comcebo0
Phone Number
+167838472200
Full Address
1900 Lake Park Drive Suite 380 Smyrna, GA 300800
CIK Number
Place of Incorporation
Investors
DUNS Number
148374205
IRS Number
870,455,0380
Founded Date
2001
0Fax Number
678-384-72810
Total Funding Amount (USD)
45,206,534
Latest Funding Round Date
June 22, 2022
Business Model
Commerce
Stock Symbol
GOVX0
Exchange
Glassdoor ID
Board of Directors
Latest Funding Type
NAICS Code
325,4120
Patents Assigned (Count)
2
Wellfound ID
Country
Headquarters
Other attributes
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
15,000,000
Previous Name
DAUPHIN TECHNOLOGY INC0
SIC Code
2,8340
Ticker Symbol
GOVX
Wikidata ID
GeoVax is a Georgia-based clinical-stage biotechnology company with a focus on researching and developing vaccines for illnesses including HIV, Ebola, HBV, HPV, and for cancer immunotherapy. The company designs its programs around a novel platform that integrates its recombinant Modified Vaccinia Ankara (MVA) vector technology with antigen design and manufacturing technologies.
COVID-19
In 2020, the company partnered with BravoVax, a Chinese pharmaceutical testing and manufacturing company. GeoVax had been conducting research for a vaccine for COVID-19 and developed three vaccine candidates. The company stated that it would narrow it down to one candidate and upon approval, commence animal studies with the vaccine.
Timeline
No Timeline data yet.
